1. Home
  2. CMCO vs CGEM Comparison

CMCO vs CGEM Comparison

Compare CMCO & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMCO
  • CGEM
  • Stock Information
  • Founded
  • CMCO 1875
  • CGEM 2016
  • Country
  • CMCO United States
  • CGEM United States
  • Employees
  • CMCO N/A
  • CGEM N/A
  • Industry
  • CMCO Construction/Ag Equipment/Trucks
  • CGEM Biotechnology: Pharmaceutical Preparations
  • Sector
  • CMCO Industrials
  • CGEM Health Care
  • Exchange
  • CMCO Nasdaq
  • CGEM Nasdaq
  • Market Cap
  • CMCO 430.3M
  • CGEM 482.7M
  • IPO Year
  • CMCO 1996
  • CGEM 2021
  • Fundamental
  • Price
  • CMCO $14.83
  • CGEM $6.29
  • Analyst Decision
  • CMCO Hold
  • CGEM Strong Buy
  • Analyst Count
  • CMCO 1
  • CGEM 8
  • Target Price
  • CMCO $35.00
  • CGEM $27.25
  • AVG Volume (30 Days)
  • CMCO 301.1K
  • CGEM 550.4K
  • Earning Date
  • CMCO 10-29-2025
  • CGEM 11-06-2025
  • Dividend Yield
  • CMCO 1.87%
  • CGEM N/A
  • EPS Growth
  • CMCO N/A
  • CGEM N/A
  • EPS
  • CMCO N/A
  • CGEM N/A
  • Revenue
  • CMCO $959,221,000.00
  • CGEM N/A
  • Revenue This Year
  • CMCO $2.95
  • CGEM N/A
  • Revenue Next Year
  • CMCO $4.09
  • CGEM N/A
  • P/E Ratio
  • CMCO N/A
  • CGEM N/A
  • Revenue Growth
  • CMCO N/A
  • CGEM N/A
  • 52 Week Low
  • CMCO $11.78
  • CGEM $6.24
  • 52 Week High
  • CMCO $41.05
  • CGEM $18.62
  • Technical
  • Relative Strength Index (RSI)
  • CMCO 50.52
  • CGEM 33.86
  • Support Level
  • CMCO $14.34
  • CGEM $6.44
  • Resistance Level
  • CMCO $14.93
  • CGEM $6.76
  • Average True Range (ATR)
  • CMCO 0.49
  • CGEM 0.41
  • MACD
  • CMCO 0.01
  • CGEM -0.10
  • Stochastic Oscillator
  • CMCO 58.47
  • CGEM 2.83

About CMCO Columbus McKinnon Corporation

Columbus McKinnon Corp is a designer, manufacturer, and marketer of intelligent motion solutions, including motion control products, technologies, automated systems, and services that efficiently and ergonomically move, lift, position, and secure materials. Its key products include hoists, crane components, precision conveyors, actuators, rigging tools, light rail workstations, and digital power and motion control systems. The company's targeted market verticals include general industries, process industries, industrial automation, and e-commerce/supply chain/warehousing among others. Geographically, the company generates a majority of its revenue from the United States and the rest from Germany, Canada, Asia Pacific, Latin America, Europe, the Middle East, and Africa.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: